Abbott Laboratories
NYSE:ABT
Abbott Laboratories
NYSE:ABT
Price:
105.27 USD
-0.59%
Market Closed
Updated:
Apr 19, 2024
Abbott Laboratories
Other Current Liabilities
Last
Value
3-Years CAGR
5-Years CAGR
|
Abbott Laboratories
Other Current Liabilities Peer Comparison
Comparables:
BDX
BSX
EW
SYK
ISRG
Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Abbott Laboratories
NYSE:ABT
|
Other Current Liabilities
$1.4B
|
CAGR 3-Years
8%
|
CAGR 5-Years
8%
|
CAGR 10-Years
0%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Other Current Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Other Current Liabilities
$944m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
12%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Other Current Liabilities
$174.3m
|
CAGR 3-Years
14%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
29%
|
|
|
Stryker Corp
NYSE:SYK
|
Other Current Liabilities
$695m
|
CAGR 3-Years
16%
|
CAGR 5-Years
13%
|
CAGR 10-Years
11%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Other Current Liabilities
$557.5m
|
CAGR 3-Years
12%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
See Also
What is Abbott Laboratories's Other Current Liabilities?
Other Current Liabilities
1.4B
USD
1.4B
USD
Based on the financial report for Dec 31, 2023, Abbott Laboratories's Other Current Liabilities amounts to 1.4B USD.
What is Abbott Laboratories's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 10Y
0%
0%
Over the last year, the Other Current Liabilities growth was 18%. The average annual Other Current Liabilities growth rates for Abbott Laboratories have been 8% over the past three years , 8% over the past five years .
You don't have any saved screeners yet
